NL0 logo

GRAIL DB:NL0 Stock Report

Last Price

€14.60

Market Cap

€483.7m

7D

-2.0%

1Y

n/a

Updated

21 Nov, 2024

Data

Company Financials +

GRAIL, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GRAIL
Historical stock prices
Current Share PriceUS$14.60
52 Week HighUS$19.30
52 Week LowUS$11.10
Beta0
11 Month Change9.77%
3 Month Change-0.68%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO18.70%

Recent News & Updates

Recent updates

Shareholder Returns

NL0DE BiotechsDE Market
7D-2.0%0.8%-1.3%
1Yn/a-17.5%7.4%

Return vs Industry: Insufficient data to determine how NL0 performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how NL0 performed against the German Market.

Price Volatility

Is NL0's price volatile compared to industry and market?
NL0 volatility
NL0 Average Weekly Movement7.7%
Biotechs Industry Average Movement6.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: NL0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine NL0's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20151,170Bob Ragusagrail.com

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests.

GRAIL, Inc. Fundamentals Summary

How do GRAIL's earnings and revenue compare to its market cap?
NL0 fundamental statistics
Market cap€483.71m
Earnings (TTM)-€2.02b
Revenue (TTM)€112.26m

4.7x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NL0 income statement (TTM)
RevenueUS$117.67m
Cost of RevenueUS$198.37m
Gross Profit-US$80.70m
Other ExpensesUS$2.04b
Earnings-US$2.12b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-63.02
Gross Margin-68.59%
Net Profit Margin-1,799.51%
Debt/Equity Ratio0%

How did NL0 perform over the long term?

See historical performance and comparison